Get started
Author

Laiyan Zhou

Psychological distress and eustress in cancer and cancer treatment: Advances and perspectives
2022 · Yuanjun Wu, Laiyan Zhou, et al. · Science Advances · 59
Pseudoprogression and hyperprogression in lung cancer: a comprehensive review of literature
2020 · Laiyan Zhou, Mai Zhang, et al. · Journal of Cancer Research and Clinical Oncology · 47
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
2023 · Xiaojuan Zhou, Laiyan Zhou, et al. · Clinical Cancer Research · 40
Low‐dose radiation therapy mobilizes antitumor immunity: New findings and future perspectives
2023 · Laiyan Zhou, Yuanxin Liu, et al. · International Journal of Cancer · 28
PDF
Safety and Tolerability Evaluation of Sintilimab in Combination with Low Dose Radiation and SBRT in Treatment Naive Stage IV PD-L1 Positive NSCLC Patients
2020 · R. Li, L. Chen, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
Real-world analysis of the incidence and risk factors of pneumonitis in non-small cell lung cancer patients treated with combined thoracic radiotherapy and immunotherapy
2024 · Yuanxin Liu, Xue Yang, et al. · ONCOLOGIE · 2
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming
2026 · Laiyan Zhou, Yuanxin Liu, et al. · Signal Transduction and Targeted Therapy · 1
PDF
Multi-omics and Mendelian randomization identify S1PR5 as a causal protective gene and NK cell-mediated prognostic biomarker in lung adenocarcinoma
2025 · Zherui Xing, Yuanxin Liu, et al. · Translational Lung Cancer Research · 1
Safety and efficacy of sintilimab in combination with SBRT and LDRT in PD-L1 positive treatment naïve-stage IV non-small cell lung cancer: A phase I study (IHC study).
2022 · Jianxin Xue, Xiaojuan Zhou, et al. · Journal of Clinical Oncology · 1
Supplementary Data 1 from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
2025 · Xiaojuan Zhou, Laiyan Zhou, et al.
[The Role of Fasting-Mimicking Diet in Cancer Therapy: Mechanisms, Challenges, and Clinical Prospects].
2025 · Yuanxin Liu, Laiyan Zhou, et al. · PubMed
Data from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naive Stage IV PD-L1+ Non-Small-Cell Lung Cancer Patients
2024 · Xiaojuan Zhou, Laiyan Zhou, et al.
Supplementary Data 1 from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naive Stage IV PD-L1+ Non-Small-Cell Lung Cancer Patients
2024 · Xiaojuan Zhou, Laiyan Zhou, et al.
Supplementary Data 1 from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naive Stage IV PD-L1+ Non-Small-Cell Lung Cancer Patients
2024 · Xiaojuan Zhou, Laiyan Zhou, et al.
Neoadjuvant Immunotherapy for non-metastatic rectal Cancer: A systematic review and meta‑analysis
2024 · Huan Zhang, Laiyan Zhou, et al.
PDF
Supplementary Data 1 from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
2023 · Xiaojuan Zhou, Laiyan Zhou, et al.
Data from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
2023 · Xiaojuan Zhou, Laiyan Zhou, et al.
Supplementary Data 1 from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
2023 · Xiaojuan Zhou, Laiyan Zhou, et al.
Data from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
2023 · Xiaojuan Zhou, Laiyan Zhou, et al.
Co-morbilities and survival of patients initially diagnosed with extensive-stage small cell lung cancer: Impact of hypertension, diabetes and chronic hepatitis B viral infection
2019 · W. Xiu, Y. Huang, et al. · Annals of Oncology
Salvage Concurrent Paclitaxel-Based Chemoradiation Therapy for Postsurgical Microscopic Residual Tumor at the Bronchial Stump (R1 Resection) in Non-Small Cell Lung Cancer
2014 · M. Zhou, C. Sun, et al. · International Journal of Radiation Oncology*Biology*Physics
Applied Analysis on the Biological Effect Dose (BED) Through the Dosimetric Comparison Between the IMRT and the VMAT Plans
2012 · S. Wang, L. Zhou, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Works count: 22
Citation count: 182
H-index: 4
I10-index: 4
Year
Topic
Type